U.S., March 28 -- ClinicalTrials.gov registry received information related to the study (NCT06899074) titled 'Omega-3 Supplementation for Pediatric Migraine' on March 20.
Brief Summary: The purpose of the study is to assess the biochemical and clinical effects of omega-3 polyunsaturated fatty acid (PUFA) supplementation in youth suffering from migraine, including its effects on migraine disability, psychological distress, and overall quality of life. This study duration 12 weeks.
Study Start Date: April, 2025
Study Type: INTERVENTIONAL
Condition:
Migraine
Intervention:
DIETARY_SUPPLEMENT: Omega 3 Polyunsaturated Fats
Omega-3 PUFA dietary supplement daily for 12 weeks. The intervention is 1 teaspoon of liquid omega-3 containing oil p...